Product NDC: | 0004-0186 |
Proprietary Name: | Boniva |
Non Proprietary Name: | ibandronate sodium |
Active Ingredient(s): | 150 mg/1 & nbsp; ibandronate sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0004-0186 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021455 |
Marketing Category: | NDA |
Start Marketing Date: | 20020715 |
Package NDC: | 0004-0186-82 |
Package Description: | 3 BLISTER PACK in 1 BOX (0004-0186-82) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0004-0186-82 |
Proprietary Name | Boniva |
Package Description | 3 BLISTER PACK in 1 BOX (0004-0186-82) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0004-0186 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ibandronate sodium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20020715 |
Marketing Category Name | NDA |
Labeler Name | Genentech, Inc. |
Substance Name | IBANDRONATE SODIUM |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |